Insulet Corp. (PODD)

153.98
NASDAQ : Health Technology
Prev Close 152.43
Day Low/High 153.41 / 155.62
52 Wk Low/High 70.80 / 155.52
Avg Volume 523.20K
Exchange NASDAQ
Shares Outstanding 60.27M
Market Cap 9.19B
EPS 0.10
P/E Ratio 544.39
Div & Yield N.A. (N.A)

Latest News

Insulet To Present At Upcoming Investor Conferences

Insulet To Present At Upcoming Investor Conferences

Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at three upcoming investor conferences: The 39 th Annual...

Insulet To Debut New Educational Self-Advocacy Tool At 20th Annual Children With Diabetes Friends For Life Conference

Insulet To Debut New Educational Self-Advocacy Tool At 20th Annual Children With Diabetes Friends For Life Conference

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced it will launch a new microsite, www.

Insulet To Announce Second Quarter 2019 Financial Results On August 5, 2019

Insulet To Announce Second Quarter 2019 Financial Results On August 5, 2019

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced plans to release its financial results for the second quarter of 2019 on...

Noteworthy Thursday Option Activity: PODD, VRS, EXP

Noteworthy Thursday Option Activity: PODD, VRS, EXP

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Insulet Corp , where a total volume of 4,111 contracts has been traded thus far today, a contract volume which is representative of approximately 411,100 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 88.1% of PODD's average daily trading volume over the past month, of 466,610 shares.

Insulet To Showcase Its Recently-Launched Omnipod® DASH™ System And Present Seven Scientific Abstracts At The American Diabetes Association's 79th Scientific Sessions

Insulet To Showcase Its Recently-Launched Omnipod® DASH™ System And Present Seven Scientific Abstracts At The American Diabetes Association's 79th Scientific Sessions

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in  tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced it will showcase its new Omnipod DASH™ Insulin Management System...

Insulet To Present At Upcoming Investor Conferences

Insulet To Present At Upcoming Investor Conferences

Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at two upcoming investor conferences: The 2019 UBS Global...

Insulet Celebrates New Global Headquarters And U.S. Manufacturing Facility In Acton, MA

Insulet Celebrates New Global Headquarters And U.S. Manufacturing Facility In Acton, MA

Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, will host a ribbon cutting ceremony today to celebrate the official grand opening of the Company's new global...

Insulet To Announce First Quarter 2019 Financial Results On May 2, 2019

Insulet To Announce First Quarter 2019 Financial Results On May 2, 2019

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced plans to release its financial results for the first quarter of 2019 on May...

Insulet To Present At Upcoming Investor Conferences

Insulet To Present At Upcoming Investor Conferences

Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at three upcoming investor conferences: The Raymond James &...

Insulet Appoints Corinne Nevinny To Board Of Directors

Insulet Appoints Corinne Nevinny To Board Of Directors

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced that Corinne Nevinny has been appointed to the Company's...

Insulet To Announce Fourth Quarter And Full Year 2018 Financial Results On February 25, 2019

Insulet To Announce Fourth Quarter And Full Year 2018 Financial Results On February 25, 2019

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced plans to release its financial results for the fourth quarter and full year of...

Insulet Appoints Wayde McMillan Chief Financial Officer

Insulet Appoints Wayde McMillan Chief Financial Officer

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced that Wayde McMillan has been appointed Executive Vice...

Insulet To Present At The 37th Annual J.P. Morgan Healthcare Conference

Insulet To Present At The 37th Annual J.P. Morgan Healthcare Conference

Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at the 37th Annual J.

Insulet's Omnipod DASH™ Insulin Management System Receives ISO 27001 Certification For Information Security

Insulet's Omnipod DASH™ Insulin Management System Receives ISO 27001 Certification For Information Security

Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced it has received ISO (International Standards Organization) 27001...

Insulet To Present At Upcoming Investor Conferences

Insulet To Present At Upcoming Investor Conferences

Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at two upcoming investor conferences: The 30th Annual Piper...

Insulet Collaborates With Samsung To Deliver Galaxy Smartphone-Controlled Insulin Pump Delivery System

Insulet Collaborates With Samsung To Deliver Galaxy Smartphone-Controlled Insulin Pump Delivery System

Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced it is collaborating with Samsung Electronics America, Inc.

Insulet Raises Awareness For National Diabetes Awareness Month

Insulet Raises Awareness For National Diabetes Awareness Month

Insulet Corporation (NASDAQ:PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced it is recognizing National Diabetes Awareness Month with initiatives that...

Omnipod® Insulin Management System Now Available For Use In Europe With Fiasp® Fast-Acting Insulin

Omnipod® Insulin Management System Now Available For Use In Europe With Fiasp® Fast-Acting Insulin

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in  tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced that Novo Nordisk's Fiasp ® (Fast-Acting Insulin Aspart) has...

Insulet To Announce Third Quarter 2018 Financial Results On November 1, 2018

Insulet To Announce Third Quarter 2018 Financial Results On November 1, 2018

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced plans to release its financial results for the third quarter of 2018...

Insulet Announces Shacey Petrovic, President And COO, Promoted To CEO, Effective January 1, 2019; Patrick Sullivan Will Retire As Chairman And CEO At The End Of 2018

Insulet Announces Shacey Petrovic, President And COO, Promoted To CEO, Effective January 1, 2019; Patrick Sullivan Will Retire As Chairman And CEO At The End Of 2018

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in  tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced that Shacey Petrovic, President and Chief Operating Officer,...

Insulet To Present At Upcoming Investor Conferences

Insulet To Present At Upcoming Investor Conferences

Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at two upcoming investor conferences in New York City, New York:...

Insulet To Showcase Its Omnipod DASH™ Insulin Management System At The American Association Of Diabetes Educators Annual Conference

Insulet To Showcase Its Omnipod DASH™ Insulin Management System At The American Association Of Diabetes Educators Annual Conference

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in  tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced it will showcase its recently FDA cleared Omnipod DASH™...

Insulet Extends Partnership With Glooko In Europe To Optimise Diabetes Data Management

Insulet Extends Partnership With Glooko In Europe To Optimise Diabetes Data Management

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in  tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced that it has partnered with Glooko ®, Inc.

Insulet To Announce Second Quarter 2018 Financial Results On August 2, 2018

Insulet To Announce Second Quarter 2018 Financial Results On August 2, 2018

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced plans to release its financial results for the second quarter of 2018...

Insulet Partners With The International Diabetes Federation Europe To Support Advocacy Activities Across The Continent

Insulet Partners With The International Diabetes Federation Europe To Support Advocacy Activities Across The Continent

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in  tubeless insulin pump technology with its Omnipod ®  Insulin Management System (Omnipod System), today announced it has entered into a partnership with the European Region...

Insulet's Omnipod Insulin Management System; Waterproof*, Tubeless Pod, And Handheld Wireless Personal Diabetes Manager With Built In BGM (Photo: Business Wire)

Insulet's Omnipod Insulin Management System; Waterproof*, Tubeless Pod, And Handheld Wireless Personal Diabetes Manager With Built In BGM (Photo: Business Wire)

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in  tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced the Omnipod System has been selected as the preferred insulin pump...

Insulet Assumes Direct Operations Of Its Omnipod® Insulin Management System Product Line In Europe

Insulet Assumes Direct Operations Of Its Omnipod® Insulin Management System Product Line In Europe

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in  tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced as of July 1, it has assumed direct commercial operations in Europe...

Insulet Presents Positive Clinical Trial Results For The Omnipod® Horizon™ Hybrid Closed-Loop System At The American Diabetes Association's 78th Scientific Sessions

Insulet Presents Positive Clinical Trial Results For The Omnipod® Horizon™ Hybrid Closed-Loop System At The American Diabetes Association's 78th Scientific Sessions

Insulet Corporation (NASDAQ:PODD) (Insulet or the Company), the leader in  tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced that positive results from the most recent clinical trial of the...

TheStreet Quant Rating: C (Hold)